Rejected at 3:09 a.m. Nov, 01, 2023 ] by Ahmed7
Author: robhornberger
Related Note: 1505934359898 2
Rationale for change

Buprenorphrine or buprenorphine/nalxone has become more a common first line treatment for OW.

Rejection reason

Please resubmit with an acceptable source.

Acceptable sources include specific UWorld QIDs + copied explanation, specific amboss article links with copied text for rationale, specific FA 2023 page numbers, and other cards in the deck (list specific nid #).

Screenshots of sources via Imgur are helpful.

Unacceptable sources include FA 2022 or older, Pathoma, B&B, Sketchy, random articles, and wikipedia.

Refer to suggestion flowchart: https://imgur.com/a/qDiVwRq
For image-related suggestions: https://imgur.com/a/bnQzo5D

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#AMBOSS::Ts068h #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::03_Opiates,_Naloxone,_Naltrexone #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#AMBOSS::yy0d3i #AK_Step2_v12::#UWorld::COMLEX::104290 #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::06_Clonidine_Guanfacine #AK_Step2_v12::#Resources_by_rotation::IM::uw::psych::psych_zanki #AK_Step2_v12::#UWorld::COMLEX::101293 #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::Original_decks::Dorian::im::uw::psych #AK_Step2_v12::#Resources_by_rotation::IM::uw::psych::psych_dorian #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Psych #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::Step::19414 #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::30_Opioid_Withdrawal,_Detoxification_and_Relapse_Prevention #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::6im #AK_Step2_v12::#B&B::13_Psych::03_Substance_Abuse::02_Substance_Abuse_I::Extra #AK_Step2_v12::!Shelf::Psych #AK_Step2_v12::#COMBANK::54328 #AK_Step1_v12::#Pixorize::3_Pharmacology::9_Psych_Drugs_(New)::7_Buprenorphine #PANCE::BEHAVIORAL::substance_use #PANCE::EOR::PSYCH #AK_Step1_v12::#Pixorize::03_Pharmacology::10_Gastrointestinal_Pharm::08_Diphenoxylate_vs._Loperamide #AK_Step2_v12::#Subjects::*Pharm_Extra::Neuro/Psych::Opioids #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step2_v12::#UWorld::Step::20489 #AK_Step2_v12::#AMBOSS::vCaAF5 #AK_Step2_v12::#UWorld::COMLEX::104771 #AK_Step2_v12::#UWorld::Step::4509 #AK_Step2_v12::#OME::04_Psychiatry::17_Addiction_2_Drugs_of_Abuse #AK_Step1_v12::#Pixorize::03_Pharmacology::04_Sympathomimetics_&_Sympatholytics::10_Clonidine_(and_Guanfacine) #AK_Step2_v12::#Subjects::*Pharm_Extra::Neuro/Psych::Opioids::Withdrawal #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview #AK_Step1_v12::#AMBOSS::ViaGq4